Publications dans lesquelles il/elle collabore avec Francisco Marin Ortuño (46)

2023

  1. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

2019

  1. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Bleeding risk prediction in patients with dual antiplatelet therapy undergoing coronary artery bypass grafting surgery using a rapid point-of-care platelet function test

    Circulation: Cardiovascular Interventions, Vol. 11, Núm. 12

  2. Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

    FASEB Journal, Vol. 32, Núm. 8, pp. 4459-4469

2017

  1. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

  2. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation

    Scientific Reports, Vol. 7

2016

  1. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 123-129

  2. Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion

    Circulation Journal, Vol. 80, Núm. 3, pp. 605-612

  3. New approaches to the role of thrombin in acute coronary syndromes: Quo Vadis bivalirudin, a direct thrombin inhibitor?

    Molecules, Vol. 21, Núm. 3

  4. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold

    Platelets, Vol. 27, Núm. 8, pp. 777-783

  5. VonWillebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

    Europace, Vol. 18, Núm. 9, pp. 1328-1334

2015

  1. Biomarkers of necrosis and myocardial remodeling

    General Methods in Biomarker Research and their Applications (Springer International Publishing), pp. 659-688

  2. CALU polymorphism A29809G affects calumenin availability involving vascular calcification

    Journal of Molecular and Cellular Cardiology, Vol. 82, pp. 218-227

  3. Colesterol HDL y troponina T ultrasensible como biomarcadores predictivos de fibrilación auricular postoperatoria

    Archivos de Cardiologia de Mexico, Vol. 85, Núm. 2, pp. 111-117

  4. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617

  5. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

    Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58

  6. Lone atrial fibrillation-a diagnosis of exclusion

    Current Pharmaceutical Design, Vol. 21, Núm. 5, pp. 544-550

  7. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 45, Núm. 2, pp. 179-186

2014

  1. Biomarkers in atrial fibrillation: An overview

    International Journal of Clinical Practice, Vol. 68, Núm. 4, pp. 434-443

  2. High-sensitivity troponin t as a biomarker for the development of atrial fibrillation after cardiac surgery

    European Journal of Cardio-thoracic Surgery, Vol. 45, Núm. 4, pp. 733-738